NVOS

Novo Integrated Sciences Inc.

Price

$0.002000

return (12m)

-96.67%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

NVOS price

Novo Integrated Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment NVOS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-48.72%

3 months

-48.72%

1 year

-96.67%

2 years

-99.12%

5 years

-99.99%

10 years

-99.99%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NVOS

Valuation

P/E

0.00

Sector 0.84

Industry -1.42

P/BV

0.00

Sector 1.82

Industry 1.25

P/Revenue (PSR)

0.00

Sector 1.48

Industry 2.13

EV/EBITDA

0.14

Sector -43.66

Industry -35.45

EV/EBIT

0.14

Sector -47.57

Industry -38.86

P/EBITDA

0.00

Sector -31.25

Industry -21.12

P/EBIT

0.00

Sector -42.58

Industry -25.59

P/Total Assets

0.00

Sector 0.82

Industry 0.70

P/Net Current Assets

0.00

Sector -23.77

Industry -59.56

P/Working Capital

0.00

Sector -3.73

Industry -1.93

EPS

-1.28

Sector -0.70

Industry -1.22

BVPS

0.51

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

37.68%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-320.63%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-77.50%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.09

Sector 0.13

Industry 0.06

Profitability

ROE

-251.86%

Sector -24.30%

Industry -38.97%

ROA

-68.86%

Sector -24.50%

Industry -49.14%

ROIC

-24.56%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.27

Sector 1.92

Industry 2.55

Net Debt / EBITDA

0.15

Sector -23.10

Industry -8.80

Net Debt / EBIT

0.14

Sector -17.84

Industry -36.75

Net Debt / Equity

-0.15

Sector -0.68

Industry -1.16

Gross Debt / Equity

0.01

Sector -0.72

Industry -0.54

Equity/Assets

0.27

Sector 0.46

Industry 0.52

Liabilities/Assets

0.73

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

5.56%

Sector -

Industry -

5Y Earnings CAGR

34.63%

Sector -

Industry -

Fundamentals NVOS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NVOS Novo Integrated Sciences Inc.	$0.002000	-96.67%	0.00%	0.00	0.00	-251.86%	-100.00%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
HCA HCA Healthcare Inc.	$454.64	7.19%	0.66%	14.90	-31.76	-213.15%	8.77%
HUM Humana Inc.	$411.55	52.12%	0.85%	39.10	2.59	6.63%	0.88%
FMS Fresenius Medical Care AG & Co.	$21.92	-17.01%	2.75%	10.92	0.77	7.01%	4.84%
DVA DaVita Inc.	$186.90	48.47%	0.00%	14.42	-25.36	-175.83%	6.05%
WTW Weight Watchers International, Inc	$312.68	-4.04%	1.21%	18.83	3.79	20.14%	15.49%
LH Laboratory Corporation of America Holdings	$317.57	12.20%	0.90%	26.07	3.03	11.62%	6.99%
ATR AptarGroup Inc	$124.68	-2.14%	1.54%	21.88	3.00	13.70%	9.22%
ALHC Alignment Healthcare Inc.	$8.25	-51.81%	0.00%	42.43	6.51	15.35%	0.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NVOS - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Novo Integrated Sciences

Novo Integrated Sciences Inc.

Average Investor10 user rating

4.0 (1 people)

United States

26 years

Founded: 2000

2005

Time since IPO - 21 years

172

Employees

Novo Integrated Sciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $38.00 Thousand, with shareholders equity totaling $9.66 million.

The company employs approximately 172 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Novo Integrated Sciences Inc. reported $13.51 million in revenue, generating net income of $-24.33 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NVOS.

Market cap

$38.00 Thousand

Net worth

$9.66 million

$9,660,000.00

Assets

$35.33 million

$35,330,000.00

Total Shares Outstanding

19.00 million

19,000,000

Average Daily Trading Volume

$4.22 Thousand

$4,219.68

Sector

Health

Industry

Health Services and Providers

NVOS

NVOS revenue and profits

Financial Results NVOS

DRAG THE FRAME TO SEE MORE DATA

NVOS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76